Roux-en-Y Gastric Bypass Versus Sleeve Gastrectomy for Super Super Obese and Super Obese: Systematic Review and Meta-analysis of Weight Results, Comorbidity Resolution
Overview
Authors
Affiliations
Background: Roux-en-Y gastric bypass (RYGB) and sleeve gastrectomy (SG) used for super obesity (SO) and super super obesity (SSO) remain controversial. The meta-analysis was to summarize the evidence.
Methods: We searched in MEDLINE and PubMed for studies concerning RYGB and SG for SO or SSO and pooled complication, percentage excess weight loss (%EWL), and resolution of comorbidities.
Results: Twelve studies were identified. RYGB achieved higher %EWL at 12 months, but no significant difference at 24 months. Resolution of diabetes mellitus and dyslipidemia reached a statistical significance; however, there was no significant difference in hypertension.
Conclusions: RYGB was superior in %EWL for SSO and SO at 12 months. However, regarding at 24 months, RYGB was equal to SG, which is from a meta-analysis and cannot be seen as a definitive conclusion.
Gaytan-Fuentes O, Barajas-Galicia E, Chavez Garcia G, Murillo Rodriguez J, Gonzalez Chavira J, Gaytan Fuentes I J Robot Surg. 2024; 18(1):382.
PMID: 39460819 DOI: 10.1007/s11701-024-02138-8.
Challenges in the care and treatment of patients with extreme obesity.
Stumpf M, Mancini M Arch Endocrinol Metab. 2024; 68:e230335.
PMID: 39420906 PMC: 11326745. DOI: 10.20945/2359-4292-2023-0335.
Singla V, Gupta A, Monga S, Kumar A, Chekuri R, Gupta M Obes Surg. 2023; 34(1):43-50.
PMID: 37996770 DOI: 10.1007/s11695-023-06960-1.
Long-term evaluation of patients with BMI = 50kg/m2 who underwent Bariatric Surgery.
Meira M, Oliveira F, Coutinho L, Leao L, Vasconcelos G, Siqueira L Rev Col Bras Cir. 2023; 50:e20233397.
PMID: 37162040 PMC: 10508685. DOI: 10.1590/0100-6991e-20233397-en.
Barzin M, Ebadinejad A, Aminian A, Khalaj A, Ghazy F, Koohi F Int J Surg. 2023; 109(3):277-286.
PMID: 37093071 PMC: 10389459. DOI: 10.1097/JS9.0000000000000203.